XTL Biopharmaceuticals Ltd ADR
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $162 | $0 | $0 |
Gross Profit | 162 | ||
EBITDA | -460 | 484 | -199 |
EBIT | -764 | -175 | -200 |
Net Income | -553 | 485 | |
Net Change In Cash | 162 | 0 | 0 |
Cash | 820 | 1,068 | 1,401 |
Basic Shares | 544,945 | 544,906 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $-459 | $1,466 | $28 |
Gross Profit | -460 | 1,465 | 27 | |
EBITDA | -764 | -879 | -1,030 | -947 |
EBIT | -765 | -880 | -1,031 | -948 |
Net Income | -1 | -1,348 | 435 | -782 |
Net Change In Cash | 0 | -459 | 1,466 | 28 |
Free Cash Flow | -707 | -901 | -1,049 | -851 |
Cash | 1,401 | 2,094 | 2,969 | 3,631 |
Basic Shares | 544,906 | 544,909 | 615,548 | 514,205 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-03-31 | $0.08 |
2023-12-31 | -$0.05 |
2023-09-30 | -$0.03 |
2023-06-30 | -$0.06 |
